Dermata Therapeutics, Inc.DRMANASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank80
3Y CAGR-4.1%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-4.1%/yr
Annual compound
Percentile
P80
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 101.56% |
| 2023 | -27.98% |
| 2022 | 63.36% |
| 2021 | 115.16% |
| 2020 | -38.71% |
| 2019 | 0.00% |